NS

Nathan Stebbins

Senior Principal at Flagship Pioneering, Co-founder & Chief Strategy & Operations Officer at Stealth NewCo

Los Angeles, California

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $500,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $7,000,000.00

Skills

Molecular Biology
Cell Culture
Data Analysis
Biochemistry
PCR
Matlab
Western Blotting
Molecular Cloning
Business Strategy
Leadership
Glycobiology
Biological Engineering
Drug Development
Infectious Diseases
Cancer Stem Cells
Analytical Biochemistry
Structural Biology
Pharmaceutical process development
Autoimmune Diseases

Education

Lists including Nathan

AP
AO
AS
AN

Based in UK

1884 people

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

FP
Flagship Pioneering

2017

  • Senior Principal

    2024

  • Principal

    2021 - 2024

  • Senior Associate

    2019 - 2021

  • Associate

    2017 - 2019

Stealth NewCo

2022

  • Founder, Chief Strategy & Operations Officer

    2022

RT
Radial Therapeutics

2019 - 2022

  • Chief Innovation Officer

    2022 - 2022

  • Founder, Chief Scientific Officer

    2019 - 2022

CB
Cobalt Biomedicine, Inc.

2018 - 2018

  • Origination Associate

    2018 - 2018

SB
Sana Biotechnology, Inc.

2018 - 2018

  • Origination Associate

    2018 - 2018

KB
Kaleido Biosciences

2017 - 2018

  • Scientific Strategy & Corporate Development

    2017 - 2018

M|
MIT | David H. Koch Institute for Integrative Cancer Research

2011 - 2017

  • Graduate Research Assistant

    2011 - 2017

    PI: Ram Sasisekharan, Ph.D.

2R
20.S947 Research Experience in Biopharma | MIT BE Department

2015 - 2016

  • Creator & Instructor

    2015 - 2016

FV
Flagship Ventures

2016 - 2016

  • Venturelabs Fellow

    2016 - 2016

MB
MIT Biotech Group

2014 - 2016

  • Founder and President

    2014 - 2016